Skip to content
Smart Money

Pharmaceuticals

CPHL Citi Pharma Ltd.

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 61.66 -0.61%

Quarterly · Q1 FY2022 – Q4 FY2026

Citi Pharma Ltd. (CPHL) quarterly cash flow statement

Operating activities generated Rs 1.1 bn of cash in Q4 FY2026 (Apr – Jun 2026), up 302.7% on Q4 FY2025. Capital expenditure was Rs 632.9 mn, leaving free cash flow of Rs 501.9 mn. Overall, cash decreased by Rs 28.9 mn.

CPHL cash flow statement (quarterly) (Rs mn)
Rs mn TTM to Jun 2026 Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023 Q3 FY2023 Jan – Mar 2023 Q2 FY2023 Oct – Dec 2022 Q1 FY2023 Jul – Sep 2022 Q4 FY2022 Apr – Jun 2022 Q3 FY2022 Jan – Mar 2022 Q2 FY2022 Oct – Dec 2021 Q1 FY2022 Jul – Sep 2021
Operating activities
Profit (cash-flow starting line, as reported) 1,344.5 (7.9) 326.4 723.7 302.3 325.8 294.2 394.2 340.3 163.2 364.9 586.5 166.6 186.2 139.2 462.6 169.3 252.7 315.2 340.2 124.9
Depreciation & amortisation 206.0 68.5 34.4 56.5 46.6 48.8 56.6 21.6 41.1 45.8 43.3 17.9 31.2 19.3 27.7 22.0 21.6 21.5 16.7 20.6 18.1
Net cash from operating activities 162.1 1,134.9 (688.4) 179.4 (463.7) 281.8 (941.4) 393.3 (54.4) (311.1) 491.8 1,111.2 45.7 (723.5) (330.2) 66.5 658.2 54.7 (408.9) 284.2 (253.0)
Investing activities
Capital expenditure (722.0) (632.9) (10.0) (41.2) (37.9) (40.6) (26.7) (122.2) (24.1) (240.0) (270.8) (255.2) (33.6) (25.0) (579.3) (66.0) (284.2) (356.3) (293.9) (64.5) (47.5)
Net cash from investing activities (643.3) (630.6) 5.3 (43.6) 25.6 49.1 (112.6) (21.9) (27.5) (8.2) (269.9) (243.4) 9.5 (713.5) 30.4 (133.6) 35.8 19.3 1,786.1 (556.3) (2,170.6)
Financing activities
Dividends paid — — (3.0) (798.2) — — — (741.4) — (1.4) 0.0 (569.8) — 0.0 0.0 — — (4.4) 0.0 (307.1) —
Borrowings raised / (repaid) 82.2 (534.1) (2,108.7) 2,867.4 (142.4) (67.8) 1,111.4 338.2 5.4 134.7 (14.1) (433.9) (74.3) 756.6 581.8 79.0 (554.2) 236.1 (64.9) 607.3 (117.4)
Net cash from financing activities (718.1) (533.2) (2,111.7) 2,069.2 (142.4) (66.8) 1,111.4 (403.2) 5.4 133.3 (14.1) (1,003.7) (74.3) 756.6 581.8 79.0 (554.2) 231.7 (64.9) 300.1 (638.8)
Net change in cash (1,199.4) (28.9) (2,794.8) 2,205.0 (580.5) 264.1 57.4 (31.8) (76.6) (186.0) 207.8 (135.9) (19.1) (680.3) 282.0 12.0 139.8 305.7 1,312.4 28.0 (3,062.4)
Key figures
Free cash flow (operating cash flow − capex) (560.0) 501.9 (698.5) 138.2 (501.6) 241.2 (968.1) 271.0 (78.5) (551.1) 221.0 856.0 12.1 (748.5) (909.5) 0.5 374.0 (301.7) (702.8) 219.7 (300.5)
CPHL cash flow statement — year-on-year change (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023 Q3 FY2023 Jan – Mar 2023 Q2 FY2023 Oct – Dec 2022 Q1 FY2023 Jul – Sep 2022 Q4 FY2022 Apr – Jun 2022 Q3 FY2022 Jan – Mar 2022 Q2 FY2022 Oct – Dec 2021 Q1 FY2022 Jul – Sep 2021
Operating activities
Profit (cash-flow starting line, as reported) -102.4% +11.0% +83.6% -11.2% +99.6% -19.4% -32.8% +104.2% -12.3% +162.2% +26.8% -1.6% -26.3% -55.8% +36.0% +35.6% — — — —
Depreciation & amortisation +40.3% -39.2% +162.0% +13.5% +6.6% +30.6% +20.4% +31.7% +137.6% +56.2% -18.4% +44.3% -10.2% +66.6% +6.4% +19.4% — — — —
Net cash from operating activities +302.7% — -54.4% — — -291.4% -64.6% -219.0% — — +1,570.7% -93.1% -1,423.5% — -76.6% — — — — —
Investing activities
Capital expenditure +1,458.8% -62.5% -66.3% +57.3% -83.1% -90.1% -52.1% -28.3% +860.4% -53.3% +286.8% -88.2% -93.0% +97.1% +2.3% +497.8% — — — —
Net cash from investing activities -1,385.6% — — — — — — -389.6% — -987.4% — -73.5% -3,796.1% -98.3% — — — — — —
Financing activities
Dividends paid — — +7.7% — — — +30.1% — — — — — -100.0% — — — — — — —
Borrowings raised / (repaid) — -289.7% +747.8% -2,755.7% -150.3% — — — -82.2% -102.4% -649.3% — +220.5% — -87.0% — — — — —
Net cash from financing activities — -290.0% — -2,755.7% -150.1% — — — -82.4% -102.4% -1,370.5% — +226.6% — -73.7% — — — — —
Net change in cash -111.0% -4,967.9% — — — -72.4% — — — -26.3% -1,236.8% -113.7% -322.6% -78.5% -57.4% — — — — —
Key figures
Free cash flow (operating cash flow − capex) +108.1% — -49.0% — — -538.1% -68.3% -748.9% — — +160,500.6% -96.8% — — -99.8% — — — — —

Change against the same quarter a year earlier; shown when the earlier figure is positive.

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. TTM = the latest four quarters added together. Updated 16 Oct 2026.

All reported line items 50
CPHL cash flow statement — all reported line items (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023
Profit/(Loss) - Starting Line - Cash Flow (7.9) 326.4 723.7 302.3 325.8 294.2 394.2 340.3 163.2 364.9 586.5 166.6
Non-cash Items & Reconciliation Adjustments - Cash Flow 218.6 138.6 190.2 117.8 202.5 174.4 60.9 118.9 193.7 133.0 17.7 135.1
Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile 43.4 24.1 53.2 (50.2) 60.0 21.7 (39.7) 24.5 33.3 26.7 (6.4) 17.1
Financial Income/(Expense) - Cash Flow - to Reconcile 106.7 80.0 80.8 121.2 98.2 91.6 76.4 56.0 99.1 43.8 70.2 86.8
Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile 68.5 34.4 56.5 46.6 48.8 56.6 21.6 41.1 45.8 43.3 17.9 31.2
Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile 68.5 34.4 56.5 46.6 48.8 56.6 21.6 41.1 45.8 43.3 17.9 31.2
Financial Assets - Unrealized Gain/(Loss) - Cash Flow - to Reconcile — 0.1 (0.3) 0.2 (4.5) 4.5 2.7 (2.7) 15.5 19.1 (63.9) —
Income Taxes - Paid/(Reimbursed) - Cash Flow 82.1 119.8 205.6 217.3 147.6 108.3 154.2 163.9 130.3 69.4 104.6 156.9
Interest Paid - Cash 159.2 64.5 111.0 58.7 94.2 121.0 61.8 79.8 70.2 70.4 72.4 77.0
Cash Flow from Operating Activities before Changes in Working Capital (30.5) 280.8 597.3 144.1 286.4 239.4 239.1 215.5 156.4 358.1 427.2 67.9
Working Capital - Increase/(Decrease) - Cash Flow 1,165.4 (969.2) (418.0) (607.8) (4.6) (1,180.7) 154.2 (269.9) (467.5) 133.8 684.0 (22.2)
Accounts Receivables - Decrease/(Increase) - Cash Flow 736.0 (197.0) (619.0) (323.2) 455.8 (584.5) (476.8) (280.2) (308.2) (341.8) 248.1 119.2
Inventories - Decrease/(Increase) - Cash Flow 692.8 (559.1) (52.3) 134.5 169.4 (252.7) (167.8) (475.3) (550.4) (33.5) 13.8 (24.3)
Prepaid Expenses - Decrease/(Increase) - Cash Flow (143.2) 33.4 101.8 (227.2) 26.0 53.2 (48.6) 47.5 (102.6) (44.9) 13.0 (12.3)
Accrued Expenses - Increase/(Decrease) - Cash Flow — — 1.6 (1.6) 5.5 6.5 (6.5) 0.0 0.9 (2.7) (24.9) 19.6
Accounts Payable and Accrued Expenses - Increase/(Decrease) - Cash Flow (120.2) (246.5) 149.9 (190.2) (661.3) (403.3) 853.9 438.0 492.9 556.6 433.9 (124.4)
Net Cash Flow from Operating Activities 1,134.9 (688.4) 179.4 (463.7) 281.8 (941.4) 393.3 (54.4) (311.1) 491.8 1,111.2 45.7
Capital Expenditures - Net - Cash Flow 632.9 (5.3) 41.2 37.9 (23.0) 26.7 122.2 24.1 8.5 270.8 255.2 33.6
Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow 632.9 10.0 19.4 37.9 40.6 7.9 13.5 24.1 240.0 47.5 26.5 12.9
Property, Plant & Equipment - Purchased - Cash Flow 632.9 10.0 19.4 37.9 40.6 7.9 13.5 24.1 240.0 47.5 26.5 12.9
Intangible Assets - Purchased/(Sold) - Net - Total - Cash Flow — (15.3) 21.8 — (63.6) 18.8 108.8 — (231.5) 223.4 228.7 20.7
Intangible Assets - Net - Cash Flow — (15.3) 21.8 — (63.6) 18.8 108.8 — (231.5) 223.4 228.7 20.7
Capital Expenditures - Total 632.9 10.0 41.2 37.9 40.6 26.7 122.2 24.1 240.0 270.8 255.2 33.6
Investments excluding Loans - Decrease/(Increase) - Cash Flow 2.3 (0.0) (2.5) 63.5 26.0 (85.9) 100.4 (3.4) 0.4 0.9 11.8 43.1
Investment Securities - Unclassified - Sold/(Purchased) - Net - Total - Cash Flow 2.3 (0.0) (2.5) 63.5 26.0 (85.9) 100.4 (3.4) 0.4 0.9 11.8 43.1
Investment Securities - Sold/Matured - Unclassified - Cash Flow — 0.1 — — 26.0 — 105.1 — 0.4 0.9 11.8 —
Investment Securities - Purchased - Unclassified - Cash Flow — 0.2 2.5 — — 85.9 4.7 3.4 — — — —
Other Investing Cash Flow - Decrease/(Increase) — — — — — — 0.0 (0.0) — — (0.0) 0.0
Net Cash Flow from Investing Activities (630.6) 5.3 (43.6) 25.6 49.1 (112.6) (21.9) (27.5) (8.2) (269.9) (243.4) 9.5
Dividends Paid - Cash - Total - Cash Flow — 3.0 798.2 — — — 741.4 — 1.4 0.0 569.8 —
Dividends - Common - Cash Paid — 3.0 798.2 — — — 741.4 — 1.4 0.0 569.8 —
Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow (534.1) (2,108.7) 2,867.4 (142.4) (67.8) 1,111.4 338.2 5.4 134.7 (14.1) (433.9) (74.3)
Debt - Issued/(Reduced) - Short-Term - Total - Cash Flow (550.2) (2,097.6) 2,785.0 (136.6) (44.2) 1,117.3 347.5 11.8 143.9 (5.8) (410.9) (58.7)
Debt - Issued - Short-Term - Cash Flow — — 2,790.7 — 2.4 1,355.7 347.5 26.2 208.2 51.9 30.5 103.8
Debt - Reduced - Short-Term - Cash Flow 550.2 2,097.6 5.7 — 46.6 238.4 — 14.5 64.3 57.7 441.4 162.6
Debt - Issued/Reduced - Long-Term - Cash Flow 16.0 (11.1) 82.4 (5.9) (23.6) (5.9) (9.3) (6.4) (9.2) (8.3) (23.1) (15.6)
Lease liabilities - Issued/(Reduced) - Cash Flow (20.2) (11.1) 5.0 (5.9) (23.6) (5.9) (2.0) (0.9) (1.8) (0.9) (0.7) (1.3)
Other Financing Cash Flow - Increase/(Decrease) 0.9 0.0 (0.0) — 1.0 0.0 0.0 (0.0) (0.0) 0.0 — —
Net Cash Flow from Financing Activities (533.2) (2,111.7) 2,069.2 (142.4) (66.8) 1,111.4 (403.2) 5.4 133.3 (14.1) (1,003.7) (74.3)
Net Change in Cash - Total (28.9) (2,794.8) 2,205.0 (580.5) 264.1 57.4 (31.8) (76.6) (186.0) 207.8 (135.9) (19.1)
Net Cash from Continuing Operations (28.9) (2,794.8) 2,205.0 (580.5) 264.1 57.4 (31.8) (76.6) (186.0) 207.8 (135.9) (19.1)
Net Cash - Beginning Balance 321.1 3,115.9 910.9 1,491.5 1,227.4 1,170.0 1,201.8 1,278.3 1,464.4 1,256.6 1,392.4 1,411.5
Net Cash - Ending Balance 292.1 321.1 3,115.9 910.9 1,491.5 1,227.4 1,170.0 1,201.8 1,278.3 1,464.4 1,256.6 1,392.4
Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental 82.1 119.8 205.6 217.3 147.6 108.3 154.2 163.9 130.3 69.4 104.6 156.9
Interest Paid - Cash Flow - Supplemental 159.2 64.5 111.0 58.7 94.2 121.0 61.8 79.8 70.2 70.4 72.4 77.0
CF from Optg Activities before Change in WC & Int Payments 128.7 345.3 708.4 202.8 380.6 360.3 300.9 295.3 226.6 428.4 499.6 144.9
Depreciation, Depletion & Amortization - Cash Flow 68.5 34.4 56.5 46.6 48.8 56.6 21.6 41.1 45.8 43.3 17.9 31.2
Free Cash Flow to Equity (32.2) (2,791.8) 3,005.6 (644.1) 237.1 143.3 609.2 (73.1) (185.0) 206.9 422.1 (62.2)
Free Cash Flow Net of Dividends 501.9 (701.5) (660.0) (501.6) 241.2 (968.1) (470.4) (78.5) (552.5) 221.0 286.2 12.1
Free Cash Flow 501.9 (698.5) 138.2 (501.6) 241.2 (968.1) 271.0 (78.5) (551.1) 221.0 856.0 12.1

Every line the company reported, in the original order and wording, without regrouping or signs changed. Latest 12 periods; the table above goes back further.